Yoko Ozawa Selected Research

Retinal Vein Occlusion

1/2022	Arm-to-retina time predicts visual outcome of anti-vascular endothelial growth factor treatment for macular edema due to central retinal vein occlusion.
12/2021	Effects of intraocular treatments for Epstein-Barr virus (EBV) retinitis: A case report.
1/2021	Closure of macular hole secondary to ischemic hemi-central retinal vein occlusion by retinal photocoagulation and topical anti-inflammatory treatment.
1/2020	Predicting recurrences of macular edema due to branch retinal vein occlusion during anti-vascular endothelial growth factor therapy.
5/2009	Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoko Ozawa Research Topics

Disease

27	Inflammation (Inflammations) 06/2020 - 08/2005
14	Choroidal Neovascularization 07/2020 - 10/2006
14	Macular Degeneration (Age-Related Maculopathy) 05/2020 - 06/2007
9	Retinal Perforations 01/2021 - 03/2008
9	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 09/2007
9	Uveitis 01/2016 - 08/2005
8	Retinal Degeneration 07/2021 - 05/2008
6	Macular Edema 01/2022 - 03/2014
5	Retinal Vein Occlusion 01/2022 - 05/2009
4	Cataract (Cataracts) 12/2021 - 12/2009
4	Epiretinal Membrane (Epiretinal Membranes) 12/2021 - 09/2014
4	Blindness (Hysterical Blindness) 08/2017 - 01/2011
3	Retinal Detachment (Retinal Detachments) 09/2021 - 03/2011
3	Retinal Diseases 01/2021 - 03/2009
3	Edema (Dropsy) 05/2020 - 03/2017
3	Ganglion Cysts (Ganglion) 03/2020 - 09/2012
3	Polypoidal Choroidal Vasculopathy 01/2019 - 01/2016
2	Retinitis 01/2021 - 01/2016
2	Infections 01/2021 - 05/2017
2	Vision Disorders (Hemeralopia) 12/2020 - 05/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 01/2012
2	Optic Nerve Diseases (Optic Neuropathy) 09/2019 - 04/2018
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2019 - 06/2014
2	Fibrosis (Cirrhosis) 03/2017 - 01/2013
2	Body Weight (Weight, Body) 01/2017 - 10/2016
2	Atopic Dermatitis (Atopic Eczema) 09/2016 - 04/2015
2	Pathologic Neovascularization 08/2013 - 01/2007
2	Hypoxia (Hypoxemia) 03/2012 - 05/2010
1	Epstein-Barr Virus Infections 12/2021
1	Papilledema 12/2021
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2021
1	Scotoma (Scintillating Scotoma) 09/2021
1	Cicatrix (Scar) 09/2021
1	Neuroinflammatory Diseases 07/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2021
1	Central Serous Chorioretinopathy 05/2021
1	Cytomegalovirus Retinitis 01/2021
1	MELAS Syndrome (Syndrome, MELAS) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021

Drug/Important Bio-Agent (IBA)

37	Retinaldehyde (Retinal)IBA 01/2022 - 12/2006
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2007
9	EndotoxinsIBA 01/2016 - 08/2005
7	LuteinIBA 08/2017 - 12/2007
7	Rhodopsin (Visual Purple)IBA 01/2016 - 12/2006
7	Type 1 Angiotensin ReceptorIBA 01/2013 - 08/2005
6	CytokinesIBA 07/2021 - 03/2007
6	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2006
6	Interleukin-6 (Interleukin 6)IBA 01/2016 - 06/2007
5	Ranibizumab (Lucentis)FDA Link 05/2020 - 09/2014
5	Neuroprotective AgentsIBA 10/2016 - 12/2006
4	AntioxidantsIBA 10/2020 - 03/2009
4	LipopolysaccharidesIBA 10/2016 - 01/2012
4	ResveratrolIBA 11/2014 - 07/2009
4	SynaptophysinIBA 01/2012 - 12/2006
3	SteroidsIBA 12/2021 - 09/2016
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2021 - 09/2014
3	Fluorescein (Funduscein)FDA LinkGeneric 05/2021 - 09/2014
3	Macular PigmentIBA 05/2020 - 12/2007
3	afliberceptIBA 01/2018 - 11/2016
3	Pharmaceutical PreparationsIBA 05/2017 - 09/2016
3	AICA ribonucleotide (ZMP)IBA 10/2016 - 11/2011
3	Oxygen (Dioxygen)IBA 08/2013 - 01/2007
3	Prorenin ReceptorIBA 07/2009 - 06/2006
3	ReninIBA 12/2008 - 06/2006
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2008 - 06/2007
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 01/2012
2	MicronutrientsIBA 08/2017 - 02/2012
2	Endothelial Growth FactorsIBA 05/2017 - 04/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016 - 12/2007
2	AMP-Activated Protein KinasesIBA 11/2014 - 11/2011
2	Therapeutic UsesIBA 01/2013 - 12/2006
2	Carotenoids (Carotene)IBA 05/2012 - 04/2008
2	Sirtuin 1IBA 11/2011 - 01/2010
2	LigandsIBA 01/2011 - 03/2007
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2011 - 09/2008
2	UbiquitinIBA 01/2011 - 09/2008
2	Eicosapentaenoic AcidIBA 07/2010 - 09/2007
2	NF-kappa B (NF-kB)IBA 07/2009 - 09/2007
2	Peptides (Polypeptides)IBA 01/2007 - 06/2006
1	Foscarnet FDA LinkGeneric 12/2021
1	Ophthalmic Solutions (Eye Drops)IBA 12/2021
1	tyramine-deoxysorbitolIBA 09/2021
1	Heme Oxygenase-1IBA 07/2021
1	Glial Fibrillary Acidic ProteinIBA 07/2021
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 07/2021
1	4-phenylbutylamineIBA 07/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	Taurine FDA Link 01/2021
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2021
1	oxidized low density lipoproteinIBA 12/2020
1	CholesterolIBA 06/2020
1	C-Reactive ProteinIBA 06/2020

Therapy/Procedure

9	Therapeutics 12/2021 - 01/2011
9	Vitrectomy 12/2021 - 03/2008
4	Lasers (Laser) 09/2021 - 01/2012
2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2013
2	Intravitreal Injections 05/2017 - 09/2014
2	Intraocular Lenses (Intraocular Lens) 04/2015 - 12/2009
1	Light Coagulation 01/2021
1	Transplantation 01/2021